{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:31Z","timestamp":1747207291923,"version":"3.40.5"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHYR"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Nebivolol has a dual mechanism of action, exerting a moderate b- block-ade effect and reducing peripheral arterial resistance, as a result, the antihypertensive effect of nebivolol may be higher than that of a potent vasodilator CCB such as amlodipine.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>The study evaluated the effect of two nebivolol\/valsartan on 24 hour ambulatory blood pres-sure versus amlodipine\/valsartan in grade II or III hypertension patients or having uncontrolled BP despite treatment. Ambulatory blood pressure monitoring is a powerful method to monitor the changes in blood pressure over the 24 hour.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>A total of 74 from 90 patients continued the study. Fourty patients re-ceived amlodipine 10 mg\/valsartan 160 mg (group I), and thirty-four patients received nebivolol 5 mg\/ valsartan 160 mg (group II). Peripheral blood pressure readings were measured at randomiza-tion at 6 and 12 weeks. Ambulatory blood pressure was measured at randomization and 12 weeks.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Both drug combinations showed high efficacy in reducing peripheral and 24 hour ambu-latory BP. There was no statistically significant difference between the groups in lowering periph-eral systolic and diastolic blood pressure at 6 and 12 weeks. Furthermore, both groups failed to show any significant difference in reducing 24 hour SBP and DBP. Regarding day SBP, the blood pressure dropped by -5.63 \u00b1 14.87 in group I and -6.25 \u00b1 11.59 in group II (p = 0.844). Also, group I reduced the day DBP average by -2.53 \u00b1 9.83 and group II by -3.61 \u00b1 9.78 (p = 0.640). In addition, both drug combinations had no statistically significant difference in lowering night SBP and DBP average.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Both treatment groups reached the target ambulatory blood pressure, and there was\nno statistically significant difference between both groups as a regard reduction in all ambulatory\nblood pressure readings.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573402119666230330082128","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T03:58:20Z","timestamp":1680235100000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Fixed-dose Combination Amlodipine\/Valsartan in Comparison to\nTwo Drug Combination Nebivolol\/Valsartan on 24-Hour Ambulatory\nBlood Pressure"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6230-1704","authenticated-orcid":true,"given":"Selvia M.","family":"Hanna","sequence":"first","affiliation":[{"name":"Cardiovascular Department, Beni-Suef University Hospital, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda M.","family":"Rabea","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E.A.","family":"Abdelrahim","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham B.","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beni-Suef University Hospital, Beni-Suef, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/IBPC.S6232","volume":"2","author":"Rubio-Guerra A.","year":"2009","unstructured":"Rubio-Guerra A.; Current concepts in combination therapy for the treatment of hypertension: Combined calcium channel blockers and RAAS inhibitors. Integr Blood Press Control 2009,2,55-62","journal-title":"Integr Blood Press Control"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/IBPC.S33985","volume":"6","author":"Mallat S.","year":"2013","unstructured":"Mallat S.; Tanios B.Y.; Itani H.S.; Current perspectives on combination therapy in the management of hypertension. Integr Blood Press Control 2013,6,69-78","journal-title":"Integr Blood Press Control"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2013.12.125","volume":"172","author":"Schmieder R.E.","year":"2014","unstructured":"Schmieder R.E.; Volpe M.; Waeber B.; Ruilope L.M.; A guide for easy- and difficult-to-treat hypertension. Int J Cardiol 2014,172(1),17-22","journal-title":"Int J Cardiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","volume":"55","author":"Gupta A.K.","year":"2010","unstructured":"Gupta A.K.; Arshad S.; Poulter N.R.; Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: A meta-analysis. Hypertension 2010,55(2),399-407","journal-title":"Hypertension"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/10641963.2016.1148160","volume":"38","author":"de la Sierra A.","year":"2016","unstructured":"de la Sierra A.; Banegas J.R.; Vinyoles E.; et al. Office and ambulatory blood pressure control in hypertensive patients treated with different two-drug and three-drug combinations. Clin Exp Hypertens 2016,38(4),409-414","journal-title":"Clin Exp Hypertens"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1586\/14779072.2016.1167598","volume":"14","author":"Sander G.E.","year":"2016","unstructured":"Sander G.E.; Fernandez C.; Giles T.D.; Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension. Expert Rev Cardiovasc Ther 2016,14(5),563-572","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/08037051.2018.1530564","volume":"27","author":"Kjeldsen S.E.","year":"2018","unstructured":"Kjeldsen S.E.; Narkiewicz K.; Burnier M.; Oparil S.; 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension. Blood Press 2018,27(6),313","journal-title":"Blood Press"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jash.2014.09.017","volume":"8","author":"Neutel J.M.","year":"2014","unstructured":"Neutel J.M.; Giles T.D.; Punzi H.; Weiss R.J.; Li H.; Finck A.; Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study. J Am Soc Hypertens 2014,8(12),915-920","journal-title":"J Am Soc Hypertens"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/01.HYP.7.2.171","volume":"7","author":"Pickering T.G.","year":"1985","unstructured":"Pickering T.G.; Harshfield G.A.; Devereux R.B.; Laragh J.H.; What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension 1985,7(2),171-177","journal-title":"Hypertension"},{"year":"2007","unstructured":"Ambulatory Blood Pressure Monitoring (ABPM) For the Clinician2007","key":"ref=10"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1097\/HJH.0000000000000969","volume":"34","author":"Stergiou G.S.","year":"2016","unstructured":"Stergiou G.S.; Parati G.; Vlachopoulos C.; et al. Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement. J Hypertens 2016,34(9),1665-1677","journal-title":"J Hypertens"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/jch.12623","volume":"17","author":"de la Sierra A.","year":"2015","unstructured":"de la Sierra A.; Gorostidi M.; Banegas J.R.; et al. Ambulatory blood pressures in hypertensive patients treated with one antihypertensive agent: Differences among drug classes and among drugs belonging to the same class. J Clin Hypertens 2015,17(11),857-865","journal-title":"J Clin Hypertens"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/10641963.2015.1060982","volume":"38","author":"Motozato K.","year":"2016","unstructured":"Motozato K.; Miura S.; Shiga Y.; et al. Efficacy and safety of two single-pill fixed-dose combinations of angiotensin II receptor blockers\/calcium channel blockers in hypertensive patients (EXAMINER study). Clin Exp Hypertens 2016,38(1),45-50","journal-title":"Clin Exp Hypertens"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2165\/11538440-000000000-00000","volume":"30","author":"da Silva P.M.","year":"2010","unstructured":"da Silva P.M.; Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: Focus on amlodipine\/valsartan. Clin Drug Investig 2010,30(9),625-641","journal-title":"Clin Drug Investig"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.clinthera.2007.03.018","volume":"29","author":"Philipp T.","year":"2007","unstructured":"Philipp T.; Smith T.R.; Glazer R.; et al. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007,29(4),563-580","journal-title":"Clin Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1524-6175.2007.06689.x","volume":"9","author":"Smith T.R.","year":"2007","unstructured":"Smith T.R.; Philipp T.; Vaisse B.; et al. Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies. J Clin Hypertens 2007,9(5),355-364","journal-title":"J Clin Hypertens"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jash.2010.03.001","volume":"4","author":"Gradman A.H.","year":"2010","unstructured":"Gradman A.H.; Basile J.N.; Carter B.L.; et al. Combination therapy in hypertension. J Am Soc Hypertens 2010,4(2),90-98","journal-title":"J Am Soc Hypertens"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2016.06.023","volume":"10","author":"Weber M.A.","year":"2016","unstructured":"Weber M.A.; Bakris G.L.; White W.B.; Xie L.; Bharucha D.; Patel M.; The effects of nebivolol-valsartan single-pill combinations in reducing blood pressure in patients with stage I or II hypertension. J Am Soc Hypertens 2016,10(S1)","journal-title":"J Am Soc Hypertens"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","volume":"31","author":"Mancia G.","year":"2013","unstructured":"Mancia G.; Fagard R.; Narkiewicz K.; et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). J Hypertens 2013,31(10),1925-1938","journal-title":"J Hypertens"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.5543\/tkda.2015.98250","volume":"44","author":"Erdogan D.","year":"2016","unstructured":"Erdogan D.; Icli A.; Aksoy F.; Akcay S.; Yucel H.; Ersoy I.; et al. The effect of fixed-dose combination of valsartan and amlodipine on nighttime blood pressure in patients with non-dipper hypertension. Turk Kardiyol Dern Ars 2016,44(5),404-413","journal-title":"Turk Kardiyol Dern Ars"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jch.12040","volume":"15","author":"Kizilirmak P.","year":"2013","unstructured":"Kizilirmak P.; Uresin Y.; Yildiz O.B.; Yildiz O.B.; The efficacy and safety of triple vs dual combination of angiotensin II receptor blocker and calcium channel blocker and diuretic: A systematic review and meta-analysis. J Clin Hypertens 2013,15(3),193-200","journal-title":"J Clin Hypertens"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.amjms.2016.10.005","volume":"353","author":"Shi R.","year":"2017","unstructured":"Shi R.; Liu K.; Shi D.; Liu Q.; Chen X.; Effects of amlodipine and valsartan on blood pressure variability and pulse wave velocity in hypertensive patients. Am J Med Sci 2017,353(1),6-11","journal-title":"Am J Med Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1751-7176.2010.00341.x","volume":"12","author":"Bakris G.L.","year":"2010","unstructured":"Bakris G.L.; Iyengar M.; Lukas M.A.; Ordronneau P.; Weber M.A.; Effect of combining extended-release carvedilol and lisinopril in hypertension: Results of the COSMOS study. J Clin Hypertens 2010,12(9),678-686","journal-title":"J Clin Hypertens"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.amjhyper.2004.03.281","volume":"17","author":"Calvo C.","year":"2004","unstructured":"Calvo C.; Ramon C.H.; Diana E.A.; Effects of nebivolol monotherapy on ambulatory blood pressure in patients with essential hypertension. Am J Hypertens 2004,17(5),S109","journal-title":"Am J Hypertens"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/ndt\/gfx152","volume":"32","author":"Cede\u00f1o Mora S.","year":"2017","unstructured":"Cede\u00f1o Mora S.; Mac\u00edas N.; Alem\u00e1n Y.; et al. Sp532effect of the blood pressure in morphological cerebral changes: Mri study in Ckd patients (Kidbrain). Nephrol Dial Transplant 2017,32(S3),308","journal-title":"Nephrol Dial Transplant"}],"container-title":["Current Hypertension Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573402119666230330082128","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215146\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573402119666230330082128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T11:43:09Z","timestamp":1696333389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215146\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573402119666230330082128","relation":{},"ISSN":["1573-4021"],"issn-type":[{"type":"print","value":"1573-4021"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}